We analyzed the public sequencing data of prostate cancer patients, finding a significant up-regulation of NK1R expression level in treatment-induced NEPC tumors, which was associated with low AR activity, high NE differentiation, and poor prognosis. The gene discussed is TACR1; the disease is prostate cancer.